Virus News and Research

Latest Virus News and Research

New point-of-care COVID-19 test can differentiate alpha variant from earlier SARS-CoV-2 strains

A point-of-care COVID-19 test developed by researchers at the University of Illinois Urbana-Champaign can now detect and differentiate the alpha variant of the SARS-CoV-2 virus from earlier strains in saliva samples.

20 Apr 2022

UCLA research finds "Long COVID" in 30% of people treated for COVID-19

New UCLA research finds that 30% of people treated for COVID-19 developed Post Acute Sequelae of COVID-19 (PASC), most commonly known as "Long COVID."

19 Apr 2022

Racism may partly contribute to high cancer burden impacting Asian Americans

The Journal of the National Cancer Institute published a commentary today on the significant cancer disparities facing Asian Americans.

19 Apr 2022

Study: Almost 40% of New York City parents are hesitant to vaccinate children for COVID-19

Almost 40 percent of New York City parents are hesitant to vaccinate their young children for COVID-19, according to a new study by researchers at the CUNY Graduate School of Public Health and Health Policy.

19 Apr 2022

Vertical transmission of SARS-CoV-2 uncommon

A new study shows that SARS-CoV-2 infection is not typically transferred to newborns from infected mothers, and if such transmission occurs, the resulting disease is usually mild.

19 Apr 2022

Wearables can identify changes in physiological systems during COVID-19 disease progression

If you become ill with COVID-19, your smartwatch can track the progression of your symptoms, and could even show how sick you become.

19 Apr 2022

Novel approach to identify targets for Wolbachia-based dengue control

Dengue is the most widespread mosquito-borne disease in the world, and to date, there are no medical treatments for people suffering from this disease.

19 Apr 2022

Fully vaccinated HIV patients may be less susceptible to develop severe breakthrough SARS-CoV-2 infection

A new study found that the risk of severe breakthrough infection of SARS-CoV-2 is low among fully vaccinated HIV patients.

19 Apr 2022

Researchers investigate Zika virus and Dengue virus co-immunity

In a new study, researchers successfully created new strains of the Zika virus and proved that the process of passaging through mice resulted in significantly increased virulence.

19 Apr 2022

NTNU researcher explores how kids are affected by coronavirus, RS virus and rhinovirus

For two years now, the novel coronavirus SARS-CoV-2 has ravaged populations the world over. Some researchers believe that the virus will mutate toward less harmless variants.

19 Apr 2022

Discovery can lead to new antiviral treatments against Crimean-Congo hemorrhagic fever

Researchers at Karolinska Institutet in Sweden have identified key signaling pathways that when blocked by existing drug candidates limit reproduction of the Crimean-Congo hemorrhagic fever (CCHF) virus.

19 Apr 2022

Why cheap, older drugs that might treat covid never get out of the lab

In March 2020, Dr. Joseph Vinetz left the contemplative world of his Yale University infectious-disease laboratory and plunged into the covid ward at Yale New Haven Hospital, joining an army of health care workers who struggled to treat the deadly viral disease.

19 Apr 2022

New, longest documented case of persistent acute SARS-CoV-2 infection

Researchers describe a 16-month-old case of SARS-CoV-2 infection in an immunocompromised individual.

18 Apr 2022

The brain's reaction to COVID's inflammatory tidal wave

Researchers study neuroinflammation in the cerebrospinal fluid and serum of patients infected with SARS-CoV-2.

18 Apr 2022

Study investigates the production of a virosome-based COVID-19 vaccine candidate

In a new study, different signal peptides, baculovirus transfer vectors, cell lines, infection techniques, and formulation buffers were investigated with the purpose of building a scalable bioprocess to generate high-quality S protein for incorporation in a virosome-based COVID-19 vaccine candidate.

18 Apr 2022

Addition of left-handed chiral gold nanoparticles can enhance vaccine efficacy by more than 25%

Vaccines can be made over 25% more effective by adding left-handed chiral gold nanoparticles as adjuvants, according to a study by an international collaboration in which Brazilian researchers took part. An article reporting the results is published in Nature.

18 Apr 2022

Attendance plummets at LA covid vaccination events

Nurse Angel Ho-king sways her head to the sound of salsa music as she waits for people willing to roll up their sleeves to get a shot. Ho-king is part of a four-person crew staffing a covid-19 vaccine table at a health fair in Rampart Village, a predominantly immigrant neighborhood about 10 minutes from Dodger Stadium.

18 Apr 2022

The involvement of the skeletal muscles in long COVID-19

Researchers reviewed the mechanisms of muscle tissue injury, aggravating conditions, and associated sequelae in long COVID‐19.

18 Apr 2022

Study identifies Etravirine and Dolutegravir as effective entry inhibitors of wild-type and predominant variants of SARS-CoV-2

Researchers identified drugs inhibiting the entry of SARS-CoV-2.

18 Apr 2022

Novel approach estimates past SARS-CoV-2 daily infections, cumulative infections, and the proportion of the population infected

In a recent study published in The Lancet, the authors estimated the global, national, and regional daily and cumulative SARS-CoV-2 infections.

18 Apr 2022

Virus News and Research

Latest Virus News and Research

New point-of-care COVID-19 test can differentiate alpha variant from earlier SARS-CoV-2 strains

UCLA research finds "Long COVID" in 30% of people treated for COVID-19

Racism may partly contribute to high cancer burden impacting Asian Americans

Study: Almost 40% of New York City parents are hesitant to vaccinate children for COVID-19

Vertical transmission of SARS-CoV-2 uncommon

Wearables can identify changes in physiological systems during COVID-19 disease progression

Novel approach to identify targets for Wolbachia-based dengue control

Fully vaccinated HIV patients may be less susceptible to develop severe breakthrough SARS-CoV-2 infection

Researchers investigate Zika virus and Dengue virus co-immunity

NTNU researcher explores how kids are affected by coronavirus, RS virus and rhinovirus

Discovery can lead to new antiviral treatments against Crimean-Congo hemorrhagic fever

Why cheap, older drugs that might treat covid never get out of the lab

New, longest documented case of persistent acute SARS-CoV-2 infection

The brain's reaction to COVID's inflammatory tidal wave

Study investigates the production of a virosome-based COVID-19 vaccine candidate

Addition of left-handed chiral gold nanoparticles can enhance vaccine efficacy by more than 25%

Attendance plummets at LA covid vaccination events

The involvement of the skeletal muscles in long COVID-19

Study identifies Etravirine and Dolutegravir as effective entry inhibitors of wild-type and predominant variants of SARS-CoV-2

Novel approach estimates past SARS-CoV-2 daily infections, cumulative infections, and the proportion of the population infected

A new way of characterising biomolecules eBook

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Newsletters you may be interested in